SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001860782-24-000009
Filing Date
2024-02-02
Accepted
2024-02-02 16:54:43
Documents
14
Period of Report
2024-01-29
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K/A tvst-20240129.htm   iXBRL 8-K/A 33008
  Complete submission text file 0001860782-24-000009.txt   164780

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT tvst-20240129.xsd EX-101.SCH 2010
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT tvst-20240129_lab.xml EX-101.LAB 24833
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT tvst-20240129_pre.xml EX-101.PRE 13144
15 EXTRACTED XBRL INSTANCE DOCUMENT tvst-20240129_htm.xml XML 2810
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02210
Business Address 60 BINNEY STREET CAMBRIDGE MA 02210 339-499-9300
2seventy bio, Inc. (Filer) CIK: 0001860782 (see all company filings)

IRS No.: 863658454 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40791 | Film No.: 24592411
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)